Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study
Hao Han,1,* Congcong Wang,2,* Fenge Jiang,2 Ping Sun,2 Jiannan Liu2 1Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, People’s Republic of China; 2Department of Oncology, The Affiliated Yantai Yuhuangding Hospit...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dove Medical Press
2025-04-01
|
| Серія: | Drug Design, Development and Therapy |
| Предмети: | |
| Онлайн доступ: | https://www.dovepress.com/comparative-analysis-of-clinical-efficacy-and-safety-of-pyrotinib-plus-peer-reviewed-fulltext-article-DDDT |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|